Phase II trial of bevacizumab and pemetrexed for recurrent or persistent epithelial ovarian, fallopian tube, or primary peritoneal cancer.
Andrea R. Hagemann
No relevant relationships to disclose
Israel Zighelboim
Research Funding - Genentech
Akiva Pesach Novetsky
No relevant relationships to disclose
Feng Gao
No relevant relationships to disclose
L. Stewart Massad
No relevant relationships to disclose
Premal H. Thaker
No relevant relationships to disclose
Matthew A. Powell
Honoraria - Genentech
Research Funding - Genentech; Lilly
David Gardner Mutch
Research Funding - Genentech
Jason D. Wright
Research Funding - Genentech